On May 18, 2022, Prescience Point Capital Management LLC issued a statement expressed its sisappoint that the MiMedx Board has resorted to disinformation and distortions to distract shareholders from the board's and management's own failures. Prescience Point reiterates its intention to withhold votes against directors Phyllis Gardner and James Bierman at 2022 annual meeting and vote against approval of executive compensation.